Genprex

About:

Genprex is a clinical-stage biopharmaceutical company developing revolutionary immunogene therapies for cancer.

Website: http://www.genprex.com

Twitter/X: genprex

Top Investors: Alliance Global Partners, Inception Fund

Description:

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.

Total Funding Amount:

$89.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)genprex.com

Founders:

Rodney Varner

Number of Employees:

11-50

Last Funding Date:

2024-03-19

IPO Status:

Public

Industries:

© 2025 bioDAO.ai